Toxicity Linked to Longer Survival in Patients With NSCLC

A new cohort study shows that some immune-related adverse events are linked to longer survival in patients with NSCLC treated with immunotherapy.

Related Keywords

Vishal Navani ,Pierre Olivier Gaudreau ,University Of Calgary ,Alberta Health Services ,Queen University In Ontario ,Medscape Medical ,Brimming Immune ,Goldilock Side ,Medscape Medical News ,Non Small Cell Lung Cancer ,Nsclc ,Lung Cancer ,Ung Carcinoma ,Ancer Of The Lung ,Canada ,Biologic Therapy ,Iologics ,Toxicology ,Toxicity ,Poisoning ,Toxins ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Small Cell Lung Cancer ,At Cell Lung Cancer ,Clc ,Immunotherapy ,Skin Cancer ,Alignant Skin Neoplasm ,Adverse Effects ,Side Effects ,Lung ,Patient Safety ,